Pulmonary tumor thrombotic microangiopathy due to lung adenocarcinoma with ROS1 rearrangement successfully treated with Crizotinib under veno-arterial extracorporeal membrane oxygenation.
Event:
ESC Congress 2019
Topic:
Clinical
Session:
Pulmonary circulation
